Glaxosmithkline pharma share price.

0.91%. $257.84B. GSK | A complete GSK overview by MarketWatch. View the latest market news and prices, and trading information.

Glaxosmithkline pharma share price. Things To Know About Glaxosmithkline pharma share price.

PE – Price Earnings Formula = Last Traded Price / EPS(TTM) PB – Price to Book Value Formula = Last Traded Price / Book Value per Share Where Book Value per Share = (Total Assets -Total Liabilities)/ No. of Equity Shares outstanding ROE – Return on Equity Formula = Profit Attributable to Equity Shareholders / Shareholder's Fund1 day ago · 2023 was marked by several first-time approvals, while some previously approved drugs came under scrutiny. by Bethany Halford. If 2022 was a sparse year for …Nov 15, 2023 · Glaxosmithkline Pharmaceuticals stock price went up today, 15 Nov 2023, by 5.97 %. The stock closed at 1470.2 per share. The stock is currently trading at 1557.9 per share. Investors should ... Glaxosmithkline Pharmaceuticals Ltd Share Price - Find the latest news updates, announcements & stock analysis for Glaxosmithkline Pharmaceuticals Ltd, including market cap, share holding pattern ... BSE STAR MF. BSE Institute Ltd. BSE SME Platform. BSE Startups. BSE Hi-Tech. BSE IPF. BSE Technologies. BSE BEAM. BSE SSE.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1655.9. Its current market capitalisation stands at Rs 27955.38 Cr. In the latest quarter, company has reported Gross Sales of Rs. 35327.42 Cr and Total Income of Rs.33178.56 Cr. The company's management includes Juby Chandy, Manu Anand, …UK multinational pharmaceutical and biotechnology firm GlaxoSmithKline (GSK) has underperformed the market in the past year as it faces US litigation and high inflation driving up costs. The GSK share price has fallen by 14% in the past year, compared with a 1% rise in the FTSE 100 Index (UK100), a 38% gain for UK rival Astrazeneca ( AZN ) and ...

GSK Pharma Share Price - Get GSK Pharma Ltd LIVE BSE/NSE stock price with Performance, Fundamentals, Market Cap, Share holding, financial report, company profile, annual report, quarterly results, profit and loss

GlaxoSmithKline Pharma Share Price Target 2023: Motilal Oswal has a 'neutral' rating on the pharma major for a target price of Rs 1,300 apiece, which implies a potential upside of Rs Rs 40 per share or 3 per cent, from the current price level of Rs 1,260. GlaxoSmithKline Pharma stock price last closed at Rs 1,259.95 at NSE. Pic: …Jul 26, 2023 · Its consolidated profit for the June quarter rose to ₹132 crore from ₹119 crore a year earlier. Shares of GlaxoSmithKline Pharmaceuticals closed marginally lower 0.1% post results on Wednesday ...Apr 26, 2020 · The company has a diverse shareholder base, which indicates that it is a popular investment choice among investors. Glaxosmithkline Pharmaceuticals Ltd. Share Price Today: CLOSE 1690, HIGH 1708, LOW: 1669.95. Get latest balance sheet, annual reports, quarterly results, and price chart.Nov 15, 2023 · Glaxosmithkline Pharmaceuticals stock price went up today, 15 Nov 2023, by 5.97 %. The stock closed at 1470.2 per share. The stock is currently trading at 1557.9 per share. Investors should ...

Dividend and share price. This section contains a collection of useful tools to enable investors to analyse current and historical GSK share prices on the London and New York stock exchanges.

Glaxosmithkline Pharmaceuticals stock price went down today, 25 Sep 2023, by -1.38 %. The stock closed at 1557.1 per share. The stock is currently trading at 1535.55 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.

Glaxosmithkline Pharmaceuticals Ltd. ₹ 1,645 -2.34%. 24 Nov - close price. Export to Excel. gsk-india.com BSE: 500660 NSE : GLAXO. About. GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. (Source : Company Web-site)Glaxosmithkline Pharmaceuticals stock price went down today, 13 Nov 2023, by -0.82 %. The stock closed at 1482.35 per share. The stock is currently trading at 1470.2 per share. Investors should ...Feb 6, 2023 · GSK plc (GSK) Sell: 1,420.60p Buy: 1,421.20p 18.40p (1.31%) FTSE 100: 0.41%. Market closed | Prices as at close on 30 November 2023 | Turn on streaming …... share price for US pharmaceutical firm Eli Lilly (LLY). GlaxoSmithKline vs Astrazeneca & Eli Lilly 5-year price chart. The company has undergone significant ...Stock split history for GlaxoSmithKline (GSK) GlaxoSmithKline stock (symbol: GSK) underwent a total of 5 stock splits. The most recent stock split occured on July 22nd, 2022. One GSK share bought prior to February 23rd, 1983 would equal to 7.8464 GSK shares today.

This page provides details of GSK's share price for stocks quoted on both the London and New York Stock Exchanges. By default, the page shows the London share price. To view US ADR data, click on the ADR tab below. London ADR You might also like Shareholder information Here you will find information and tools for GSK shareholders including our… GSK:LSE trading volume exceeds daily average by +113.76% Nov 30 2023; GSK:LSE price moved over +1.01% to 1,415.20 Nov 30 2023; GSK:LSE price rises above 200-day moving average to 1,426.00 at 08:00 GMT Dec 01 2023; GSK:LSE price rises above 200-day moving average to 1,423.40 at 13:24 GMT Nov 30 2023This page provides details of GSK's share price for stocks quoted on both the London and New York Stock Exchanges. By default, the page shows the London share price. To view US ADR data, click on the ADR tab below. London ADR You might also like Shareholder information Here you will find information and tools for GSK shareholders including our… Jun 23, 2023 · View the latest GSK PLC ADR (GSK) stock price, news, historical charts, analyst ratings and financial information from WSJ.As of November 2023 GlaxoSmithKline has a market cap of $74.07 Billion . This makes GlaxoSmithKline the world's 197th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how ...

Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.

Oct 10, 2023 · Glaxosmithkline Pharmaceuticals' stock opened at ₹ 1540.25 and closed at ₹ 1550.25 on the last trading day. The stock had a high of ₹ 1565.15 and a low of ₹ 1529.6 during the day. The company's market capitalization is ₹ 25912.35 crore. The 52-week high and low for the stock are ₹ 1622.95 and ₹ 1228, respectively. The stock had a trading …Submarine workers and sailors took to the internet to share what it’s like exploring the deep, dark ocean and to clear up some misconceptions—we don’t all live in a yellow submarine, after all. And according to them, it’s not all fun and ga...Sun Pharmaceutical Industries share price; 1,191.45-0.41%; ITC share price; 436.05-0.4%; ... GlaxoSmithKline Pharmaceuticals had a one-off gain from the sale of surplus residential properties ...Pharma historical data. Check Glaxosmithkline Pharmaceuticals Ltd Share Price History in a daily, weekly and monthly format back to when stock was listed at IIFL Investor Relations Based on the share price today, this will cut the total dividend yield from 5% to just 3.4%. There’s even less clarity about 2023. The GSK pharma business is expected to pay a dividend of 45p ...What is the Share price of Glaxosmithkline Pharmaceuticals (GLAXO)? Glaxosmithkline Pharmaceuticals (GLAXO) share price as of December 1, 2023, on NSE is Rs 1,678.15 (NSE) and Rs 1,671.00 (BSE) on BSE.UK multinational pharmaceutical and biotechnology firm GlaxoSmithKline (GSK) has underperformed the market in the past year as it faces US litigation and high inflation driving up costs. The GSK share price has fallen by 14% in the past year, compared with a 1% rise in the FTSE 100 Index (UK100), a 38% gain for UK rival Astrazeneca ( AZN ) and ...View 5 reports from 2 analysts offering long term price targets for GlaxoSmithKline Pharmaceuticals Ltd.. GlaxoSmithKline Pharmaceuticals Ltd. has an average target of 1335.00. The consensus estimate represents a downside of -19.58% from the last price of 1660.10. Reco - This broker has downgraded this stock from it's previous report.1.21B. -94.01%. Get the latest GSK plc (GSK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Glaxosmithkline Pharmaceuticals Ltd. ₹ 1,645 -2.34%. 24 Nov - close price. Export to Excel. gsk-india.com BSE: 500660 NSE : GLAXO. About. GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people. (Source : Company Web-site)

Ordinary: 19p. ADR: $0.4739139. 2020 Total. Ordinary: 80p. ADR: $2.1201682. *Payment amount for each dividend will be published on each payment date. **When adjusted for the GSK share consolidation which was implemented on 18 July 2022 the total dividend for 2022 was 61.25 pence.

Glaxosmithkline Pharmaceuticals stock price went down today, 14 Sep 2023, by -0.44 %. The stock closed at 1546.75 per share. The stock is currently trading at 1539.9 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news.

AstraZeneca is trading on a price-to-earnings ratio of 52. In sharp contrast, Glaxo’s P/E ratio is just 13. In other words, the GlaxoSmithKline share price looks four times as cheap on this ...5 day moving crossover appeared on Dec 01, 2023. Average price decline of -2.63% within 7 days of this signal in last 5 years. Polycab India Share Price Update. Polycab India Ltd. share price moved down by -0.63% from its previous close of Rs 5,267.90. Polycab India Ltd. stock last traded price is 5,234.55. Share Price.Oct 2, 2023 · Glaxosmithkline Pharmaceuticals stock price went up today, 03 Oct 2023, by 1.55 %. The stock closed at 1544.5 per share. The stock is currently trading at 1568.5 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news. 0.91%. $257.84B. GSK | A complete GSK overview by MarketWatch. View the latest market news and prices, and trading information.Dec 1, 2023 · Glaxosmithkline Pharmaceuticals Ltd share price was up by 1.27% from the previous closing price of ₹1,657.10. Glaxosmithkline Pharmaceuticals. is trading-2.42% lower at Rs 1,645.00 as compared to its last closing price.. Glaxosmithkline Pharmaceuticals has been trading in the price range of 1,706.00 ... Shares of GlaxoSmithKline Pharmaceuticals closed at Rs 1,514.50 per scrip on BSE, up 1.42 per cent from its previous close. ... Net profit soars 82% on high oil prices. Published on: May 16, 2022 ...GSK GlaxoSmithKline Pharmaceuticals share price as of today is ₹ -.The company has a market capitalization of ₹ -with a P/E ratio of -.Over the past 1 year, GSK GlaxoSmithKline Pharmaceuticals's share price has moved by -while the 5-year performance of the stock stands at .You' d also be interested to know that GSK GlaxoSmithKline …Discover historical prices for GLAXO.NS stock on Yahoo Finance. View daily, weekly or monthly format back to when GlaxoSmithKline Pharmaceuticals Limited stock was issued.Sep 29, 2023 · GlaxoSmithKline Pharma share price Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. GlaxoSmithKline Pharma share price Blogs, Comments and Archive News on Economictimes.comGlaxoSmithKline Pharmaceuticals Ltd Share Price Today - Get GlaxoSmithKline Pharmaceuticals Ltd Share price LIVE on NSE/BSE and Price Chart, News, Announcements, Company Profile, Financial Statements, Company Holdings, Forecasts, Annual Reports and more!

GSK plc (GSK) ADR Each Repr 2 Ord Shares GBP0.25. GSK plc (GSK) Sell: $36.47 Buy: $36.59 $0.58 (1.61%) Market closed | Prices as at close on 1 December 2023 | Turn on streaming prices. Ex-dividend ...1,537.50p. (6.98% Upside) Based on 7 Wall Street analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. The average price target is 1,537.50p with a high forecast of 1,700.00p and a low forecast of 1,300.00p. The average price target represents a 6.98% change from the last price of 1,437.20p.Oct 12, 2023 · Glaxosmithkline Pharmaceuticals stock price went down today, 12 Oct 2023, by -0.79 %. The stock closed at 1534.25 per share. The stock is currently trading at 1522.1 per share. Investors should monitor Glaxosmithkline Pharmaceuticals stock price closely in the coming days and weeks to see how it reacts to the news. Instagram:https://instagram. which forex broker has the highest leveragebest california dental insurancejsvaxnon qm lender The GlaxoSmithkline Pharmaceuticals stock price may drop from 1677.050 INR to 1614.587 INR . The change will be -3.725%. Will Glaxosmithkline Pharmaceuticals ... mainstreet capitalmaterials Oct 27, 2023 · Shares; GlaxoSmithkline Pharma; Historical Price; GlaxoSmithkline Pharmaceuticals Ltd (GLAX) Get free historical data for GLAX. You'll find the closing …May 17, 2022 · GlaxoSmithKline Pharmaceuticals on Monday reported a Rs 55 crore consolidated net loss from continuing operations for the fourth quarter. The drug firm had reported a net profit of Rs 4 crore for the January-March quarter of the 2020-21 fiscal. Revenue from operations rose to Rs 810 crore for the fourth quarter compared to Rs 744 … best robot stocks We've built an agile network, with the capacity and capability to bring the next generation of medicines to patients all over the globe. Packs of medicines delivered in 2022. 1.8bn. Our portfolio spans three product areas: vaccines, specialty and general medicines.PE – Price Earnings Formula = Last Traded Price / EPS(TTM) PB – Price to Book Value Formula = Last Traded Price / Book Value per Share Where Book Value per Share = (Total Assets -Total Liabilities)/ No. of Equity Shares outstanding ROE – Return on Equity Formula = Profit Attributable to Equity Shareholders / Shareholder's Fund